InsiderSignalSign in

← Insider buys

EW

Edwards Lifesciences Corporation · Healthcare

Insiders sold $25.5M of Edwards Lifesciences Corporation in the last 12 months and bought none

$0Bought, 12 mo

$25.5MSold, 12 mo

$51.3BMarket cap

EW over the last year

No insider buys filed in this year

EW after insider buys

3 months after each buy, from the first price a copier could get.

2 buys have 3 months of prices so far. A record shows here at 3.

Congress

Members reported 41 trades in EW since 2023.

Every filing

584 insider filings since 2016, newest first

Daniel J. Lippis · CVP, TAVR

$53K−1.5%Oct 8

Daniel J. Lippis · CVP, TAVR

$54K−1.5%Sep 11

Andrew M. Dahl · SVP, Corporate Controller

$50K−3.5%Aug 31

Annette Bruls · CVP, EMEACLA

$238K−12.8%Aug 28

Daveen Chopra · CVP, TMTT, Surgical & IHFM

$2.9M−41.8%Aug 26

Wayne Markowitz · CVP, JAPAC

$113K−5.8%Aug 26

Daniel J. Lippis · CVP, TAVR

$57K−1.5%Aug 11

Wayne Markowitz · CVP, JAPAC

$819K−30.8%Jul 28

Bernard J Zovighian · CEO

$245K−24.7%Jul 27

Daniel J. Lippis · CVP, TAVR

$57K−1.5%Jul 10

Daniel J. Lippis · CVP, TAVR

$57K−1.5%Jul 1

Bernard J Zovighian · CEO

$46K−4.3%Jun 18

Andrew M. Dahl · SVP, Corporate Controller

$49K−3.6%May 29

Donald E Bobo Jr · CVP,Strategy/Corp Development

$2.0M−19.0%May 27

Daveen Chopra · CVP, TMTT, Surgical

$127K−3.0%May 22

Daniel J. Lippis · CVP, TAVR

$50K−2.0%May 18

Donald E Bobo Jr · CVP,Strategy, Corp Development

$1.5M−9.0%May 18

Bernard J Zovighian · CEO

$2.8M−24.0%May 12

Wayne Markowitz · CVP, JAPAC

$47K−3.0%May 11

Daniel J. Lippis · CVP, TAVR

$170K−6.0%May 4

Daniel J. Lippis · CVP, TAVR

$83K−3.0%Apr 6

Donald E Bobo Jr · CVP,Strategy, Corp Development

$1.8M−11.0%Apr 2

Scott B. Ullem · CVP, CFO

$1.1M−4.0%Mar 11

Daniel J. Lippis · CVP, TAVR

$87K−3.0%Mar 11

Donald E Bobo Jr · CVP,Strategy, Corp Development

$974K−6.0%Mar 2

Donald E Bobo Jr · CVP,Strategy, Corp Development

$2.0M−12.0%Feb 26

Bernard J Zovighian · CEO

$1.7M−19.0%Feb 13

Daniel J. Lippis · CVP, TAVR

$87K−4.0%Jan 9

Donald E Bobo Jr · CVP,Strategy, Corp Development

$971K−5.0%Jan 6

Donald E Bobo Jr · CVP,Strategy, Corp Development

$954K−5.0%Dec 12

Daniel J. Lippis · CVP, JAPAC

$86K−4.0%Dec 12

Heisz Leslie Stone · Director

$218K−8.0%Dec 12

Daveen Chopra · CVP, TMTT, Surgical

$169K−6.0%Dec 11

Donald E Bobo Jr · CVP,Strategy, Corp Development

$951K−5.0%Dec 10

Bernard J Zovighian · CEO

$2.2M−21.0%Dec 10

Scott B. Ullem · CVP, CFO

$650K−2.0%Dec 9

Wayne Markowitz · CVP, JAPAC

$50K−3.0%Dec 8

Donald E Bobo Jr · CVP,Strategy, Corp Development

$328K−2.0%Nov 13

Larry L Wood · Global Pres TAVR, Surg

$1.6M−11.0%Nov 5

Donald E Bobo Jr · CVP,Strategy, Corp Development

$348K−2.0%Oct 15

Donald E Bobo Jr · CVP,Strategy, Corp Development

$334K−2.0%Sep 11

Daveen Chopra · CVP, TMTT

$87K−4.0%Aug 20

Donald E Bobo Jr · CVP,Strategy, Corp Development

$330K−2.0%Aug 14

Daniel J. Lippis · CVP, JAPAC

$47K−2.0%Jul 11

Donald E Bobo Jr · CVP,Strategy, Corp Development

$466K−2.0%Jul 10

Daniel J. Lippis · CVP, JAPAC

$48K−2.0%Jun 20

Scott B. Ullem · CVP, CFO

$492K−2.0%Jun 20

Donald E Bobo Jr · CVP,Strategy, Corp Development

$438K−2.0%Jun 12

Bernard J Zovighian · CEO

$756K−11.0%May 30

Scott B. Ullem · CVP, CFO

$509K−2.0%May 21

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.